Tesamorelin & Ipamorelin Peptide Stack

Description

Buy Tesamorelin Ipamorelin Peptide Stack Canada

This product is intended for research purposes only. To be used by trained professionals only.

Tesamorelin Ipamorelin peptides work together to stimulate the pituitary gland, boosting the synthesis and secretion of endogenous growth hormone to youthful levels. The combination of these peptides can enhance sleep, metabolic function, cognition, and triglyceride levels.

Tesamorelin

Canada Research investigations have provided evidence that Tesamorelin operates by acting as a growth hormone-releasing factor (GHRF) peptide, so prompting the body to increase its production of growth hormone. It facilitates the release of growth hormone by aiding the Pituitary Gland located in the brain. The growth hormone-releasing factor (GHRF) enhances the metabolic rate, leading to a decrease in adipose tissue in the abdomen region, with improved energy usage efficiency. According to existing research, it has been found that Tesamorelin exhibits a larger potential in reducing abdominal fat compared to Human Growth Hormone (HGH).

The Tesamorelin peptide is specifically formulated to mitigate the occurrence of lipodystrophy and excessive adipose tissue accumulation in the abdominal area among persons afflicted with HIV infection. Furthermore, empirical studies have demonstrated that the administration of Tesamorelin peptide has the potential to decrease visceral adipose tissue in persons who are not infected by the human immunodeficiency virus (HIV).

Ipamorelin

Ipamorelin is a synthetic pentapeptide that is created from the growth hormone GHRP-1. It consists of a sequence of five amino acids. Additionally, it is a peptide hormone that is employed to augment the levels of growth hormone in the body. Ipamorelin functions as an agonist by binding to the growth hormone secretagogue receptor (GHSR), thereby initiating its activation and subsequently inducing a biological response. The receptor is located within the ventromedial nucleus of the hypothalamus (VMN), where it plays a role in controlling energy homeostasis and body weight by modifying the regulation of calorie intake and hunger sensations.

According to existing Canada research, it has been found that Ipamorelin has the ability to induce the synthesis of growth hormone agents by activating the ghrelin receptor located in the human brain. The activation of this receptor and the subsequent elevation of growth hormone agents have the potential to influence various physiological processes, including food intake, basal metabolism, as well as sugar and fat metabolism.

Research findings have demonstrated the potential efficacy of Ipamorelin in mitigating the deterioration of bone and muscle mass integrity. Additionally, it induces the activation of the Pituitary Gland, leading to an increased production of growth hormone agents. Ipamorelin is a distinct growth hormone stimulant that does not induce elevations in prolactin, follicle-stimulating hormone, luteinizing hormone, or thyroid-stimulating hormone levels. Furthermore, various pieces Canada research have provided evidence suggesting that Ipamorelin does not exhibit any significant effects on the secretion of adrenocorticotropic hormones or the stimulation of cortisol. This suggests that Ipamorelin does not possess lipogenic qualities and does not have the ability to increase appetite.

The peptide has also been shown to increase levels of human growth hormone, leading to a rejuvenated appearance characterized by enhanced hair and nail thickness. Moreover, empirical research has demonstrated the anti-aging effects of Ipamorelin by mitigating the depletion of collagen in the dermis, hence attenuating the development of fine lines and wrinkles.

The combined administration of Tesamorelin Ipamorelin has been shown to exhibit a synergistic effect in promoting the activation of the pituitary gland, leading to enhanced production and secretion of endogenous growth hormone at levels reminiscent of youth. The combination of the Tesamorelin Ipamorelin peptides can yield additional advantages such as enhanced sleep quality, optimized metabolic function, increased cognitive abilities, and a reduction in triglyceride levels.

References:

[1] https://www.medscape.com/view article/758381

[2] https://www.ncbi.nlm.nih.gov/ pubmed/20554713

[3] https://www.ncbi.nlm.nih.gov/ books/NBK548730/

[4] https://www.ncbi.nlm.nih.gov/ pubmed/27186127

[5] https://www.sciencedirect.com/ science/article/abs/pii/S10966374 99999987

[6] https://www.ncbi.nlm.nih.gov/ pubmed/10373343

[7] https://pubmed.ncbi.nlm.nih. gov/9849822/

Ipamorelin Specifications

Sequence: H-Aib-His-D-2Nal-D-Phe-Lys-NH2

Molecular Formula: C38H49N9O5

Molecular Weight: 711.868 g/mol

Tesamorelin Specifications

Molecular Formula: C221H366N72O67S

Molecular Weight: 5135.77

Sequence: trans-hexenoyl-acid-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn- Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-LeuGln-Asp-Ile-Met-Ser-Arg-Gln- Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2

Storage: Lyophilized peptides to be stored below -18°C

Research use only. Not for human or animal consumption!

ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Canada Direct Peptides website: https://canada.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.

BUY Tesamorelin Ipamorelin Peptide Stack ONLINE today From Canada Direct Peptides